As of 9:30 AM on the 7th, Eugene is trading at 15,800 KRW, down 2.47% from the previous day. This represents a 54.9% increase compared to July 14. Eugene is known as a biopharmaceutical development company.
Over the past 5 days, individual investors have net sold 156,091 shares, while foreigners and institutions have net bought 138,369 shares and 2,481 shares, respectively.

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
